ARTICLE | Company News
Orion Pharma, Population Council deal
April 24, 2000 7:00 AM UTC
The council will grant Orion exclusive worldwide rights to develop, commercialize and sublicense Nestorone synthetic progestin in transdermal dosage forms other than the patch for hormone replacement ...